140 related articles for article (PubMed ID: 17113074)
1. Trishomocubanes: novel sigma ligands modulate cocaine-induced behavioural effects.
Liu X; Banister SD; Christie MJ; Banati R; Meikle S; Coster MJ; Kassiou M
Eur J Pharmacol; 2007 Jan; 555(1):37-42. PubMed ID: 17113074
[TBL] [Abstract][Full Text] [Related]
2. Behavioural effects of trishomocubanes in rats with unilateral 6-hydroxydopamine lesions.
van Dijk A; Johnston C; Allbutt H; Kassiou M; Henderson J
Behav Brain Res; 2008 Jun; 190(1):14-21. PubMed ID: 18378329
[TBL] [Abstract][Full Text] [Related]
3. Trishomocubanes: novel sigma-receptor ligands modulate amphetamine-stimulated [3H]dopamine release.
Liu X; Nuwayhid S; Christie MJ; Kassiou M; Werling LL
Eur J Pharmacol; 2001 Jun; 422(1-3):39-45. PubMed ID: 11430911
[TBL] [Abstract][Full Text] [Related]
4. Cocaine occupancy of sigma1 receptors and dopamine transporters in mice.
Lever JR; Fergason-Cantrell EA; Watkinson LD; Carmack TL; Lord SA; Xu R; Miller DK; Lever SZ
Synapse; 2016 Mar; 70(3):98-111. PubMed ID: 26618331
[TBL] [Abstract][Full Text] [Related]
5. A selective sigma-2 receptor ligand antagonizes cocaine-induced hyperlocomotion in mice.
Lever JR; Miller DK; Green CL; Fergason-Cantrell EA; Watkinson LD; Carmack TL; Fan KH; Lever SZ
Synapse; 2014 Feb; 68(2):73-84. PubMed ID: 24123353
[TBL] [Abstract][Full Text] [Related]
6. Novel sigma receptor ligands attenuate the locomotor stimulatory effects of cocaine.
McCracken KA; Bowen WD; Matsumoto RR
Eur J Pharmacol; 1999 Jan; 365(1):35-8. PubMed ID: 9988120
[TBL] [Abstract][Full Text] [Related]
7. Effects of the selective sigma receptor ligand, 6-[6-(4-hydroxypiperidinyl)hexyloxy]-3-methylflavone (NPC 16377), on behavioral and toxic effects of cocaine.
Witkin JM; Terry P; Menkel M; Hickey P; Pontecorvo M; Ferkany J; Katz JL
J Pharmacol Exp Ther; 1993 Aug; 266(2):473-82. PubMed ID: 8355185
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and quantitative structure-activity relationships of N-(1-benzylpiperidin-4-yl)phenylacetamides and related analogues as potent and selective sigma1 receptor ligands.
Huang Y; Hammond PS; Whirrett BR; Kuhner RJ; Wu L; Childers SR; Mach RH
J Med Chem; 1998 Jun; 41(13):2361-70. PubMed ID: 9632369
[TBL] [Abstract][Full Text] [Related]
9. Dual probes for the dopamine transporter and sigma1 receptors: novel piperazinyl alkyl-bis(4'-fluorophenyl)amine analogues as potential cocaine-abuse therapeutic agents.
Cao J; Kulkarni SS; Husbands SM; Bowen WD; Williams W; Kopajtic T; Katz JL; George C; Newman AH
J Med Chem; 2003 Jun; 46(13):2589-98. PubMed ID: 12801223
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationship studies on a novel series of (S)-2beta-substituted 3alpha-[bis(4-fluoro- or 4-chlorophenyl)methoxy]tropane analogues for in vivo investigation.
Zou MF; Cao J; Kopajtic T; Desai RI; Katz JL; Newman AH
J Med Chem; 2006 Oct; 49(21):6391-9. PubMed ID: 17034144
[TBL] [Abstract][Full Text] [Related]
11. Effects of N-substituted analogs of benztropine: diminished cocaine-like effects in dopamine transporter ligands.
Katz JL; Kopajtic TA; Agoston GE; Newman AH
J Pharmacol Exp Ther; 2004 May; 309(2):650-60. PubMed ID: 14755006
[TBL] [Abstract][Full Text] [Related]
12. Behavioral effects of rimcazole analogues alone and in combination with cocaine.
Katz JL; Libby TA; Kopajtic T; Husbands SM; Newman AH
Eur J Pharmacol; 2003 May; 468(2):109-19. PubMed ID: 12742518
[TBL] [Abstract][Full Text] [Related]
13. Novel 3alpha-diphenylmethoxytropane analogs: selective dopamine uptake inhibitors with behavioral effects distinct from those of cocaine.
Katz JL; Izenwasser S; Kline RH; Allen AC; Newman AH
J Pharmacol Exp Ther; 1999 Jan; 288(1):302-15. PubMed ID: 9862785
[TBL] [Abstract][Full Text] [Related]
14. Effects of UMB24 and (+/-)-SM 21, putative sigma2-preferring antagonists, on behavioral toxic and stimulant effects of cocaine in mice.
Matsumoto RR; Pouw B; Mack AL; Daniels A; Coop A
Pharmacol Biochem Behav; 2007 Jan; 86(1):86-91. PubMed ID: 17241657
[TBL] [Abstract][Full Text] [Related]
15. Comparison of interactions of D1-like agonists, SKF 81297, SKF 82958 and A-77636, with cocaine: locomotor activity and drug discrimination studies in rodents.
Chausmer AL; Katz JL
Psychopharmacology (Berl); 2002 Jan; 159(2):145-53. PubMed ID: 11862342
[TBL] [Abstract][Full Text] [Related]
16. Relationship between cerebral sigma-1 receptor occupancy and attenuation of cocaine's motor stimulatory effects in mice by PD144418.
Lever JR; Miller DK; Fergason-Cantrell EA; Green CL; Watkinson LD; Carmack TL; Lever SZ
J Pharmacol Exp Ther; 2014 Oct; 351(1):153-63. PubMed ID: 25100754
[TBL] [Abstract][Full Text] [Related]
17. N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as σ receptor ligands with potential neuroprotective effects.
Banister SD; Manoli M; Barron ML; Werry EL; Kassiou M
Bioorg Med Chem; 2013 Oct; 21(19):6038-52. PubMed ID: 23981939
[TBL] [Abstract][Full Text] [Related]
18. Trishomocubane as a scaffold for the development of selective dopamine transporter (DAT) ligands.
Banister SD; Moussa IA; Beinat C; Reynolds AJ; Schiavini P; Jorgensen WT; Kassiou M
Bioorg Med Chem Lett; 2011 Jan; 21(1):38-41. PubMed ID: 21146989
[TBL] [Abstract][Full Text] [Related]
19. Conformationally restricted analogs of BD1008 and an antisense oligodeoxynucleotide targeting sigma1 receptors produce anti-cocaine effects in mice.
Matsumoto RR; McCracken KA; Friedman MJ; Pouw B; De Costa BR; Bowen WD
Eur J Pharmacol; 2001 May; 419(2-3):163-74. PubMed ID: 11426838
[TBL] [Abstract][Full Text] [Related]
20. Antagonism of 5-hydroxytryptamine(2a) receptors attenuates the behavioral effects of cocaine in rats.
McMahon LR; Cunningham KA
J Pharmacol Exp Ther; 2001 Apr; 297(1):357-63. PubMed ID: 11259563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
